Clearside Biomedical shares down on Q4 miss
Shares in Clearside Biomedical (NSDQ:CLSD) have fallen slightly today after the biopharmaceutical company posted fourth quarter 2018 earnings that missed expectations on Wall Street. The Alpharetta, Ga.-based company reported research and development costs of approximately $17.5 million with a total net loss of $21.6 million, or 68¢ per share, for the three months ended December 31, seeing R&D costs grow 25.5% while losses grew 31.2% when compared with the same period during the previous year. Read the whole story on our sister site, Drug Delivery Business News The post Clearside Biomedical shares down on Q4 ...
Source: Mass Device - March 13, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Clearside Biomedical Source Type: news

Biogen to sell Denmark-based manufacturing site to FujiFilm for $890m
Biogen (NSDQ:BIIB) said yesterday that it inked an $890 million deal to sell a Denmark-based manufacturing site to Fujifilm (TSE:4901). The site, located in Hillerød, includes a biologics production facility with assembly, labeling and packing capabilities as well as quality control laboratories and warehouses, Cambridge, Mass.-based Biogen said. The facility also has approximately 800 employees who are expected to continue to work under Fujifilm. “We continually evaluate our manufacturing strategy and we believe that this agreement serves the best interest of our employees, customers, partners and s...
Source: Mass Device - March 13, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Biogen fujifilm Source Type: news

Corindus Vascular Robotics meets The Street with Q4 earnings
Corindus Vascular Robotics (OTC:CVRS) shares gained today after the robot-assisted surgery company reported fourth-quarter results that met the forecast on Wall Street. Losses grew 3.1% for Waltham, Mass.-based Corindus posted to -$8.2 million, or -4¢ per share, on sales growth of 11.5% to $4.7 million for the three months ended Dec. 31, 2018, compared with the same period in 2017. Analysts were looking for LPS of -4¢. Full-year losses were ip 25.0% to -$42.6 million, or -22¢ per share, on sales growth of 11.7% to $10.8 million compared with 2017. “2019 is poised to be another significant year for Cori...
Source: Mass Device - March 13, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular MassDevice Earnings Roundup Robotics Wall Street Beat Corindus Vascular Robotics Source Type: news

Sientra plunges on Q4 earnings miss, clouded outlook
A fourth-quarter earnings miss and the uncertainty around an upcoming FDA advisory panel meeting on breast implants sent Sientra (NSDQ:SIEN) shares down precipitously today. The Santa Barbara, Calif.-based medical aesthetics company’s losses widened 38.1% to -$24.6 million, or 86¢ per share, on sales growth of 71.9% to $19.0 million for the three months ended Dec. 31, 2018, compared with Q4 2017. Analysts on Wall Street were looking for losses of -68¢. Full-year losses were up 29.0% to -$82.6 million, or -$3.25 per share, on sales growth of 86.4% to $68.1 million compared with the prior year, Sientra said. ...
Source: Mass Device - March 13, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cosmetic/Aesthetic MassDevice Earnings Roundup Wall Street Beat Women's Health Sientra Source Type: news

Senseonics shares dip on Q4 sales miss, lowered guidance
Shares in Senseonics (NYSE:SENS) fell slightly today after the diabetes-focused device maker posted fourth quarter and full year 2018 earnings that beat loss-per-share consensus but missed sales expectations and lowered its guidance for the 2019 fiscal year. The Germantown, Md.-based company posted losses of $7.3 million, or 4¢ per share, on sales of $7.2 million for the three months ended December 31, seeing losses shrink 55.2% while sales grew 148.3% compared with the same period during the previous year. Read the whole story on our sister site, Drug Delivery Business News The post Senseonics shares dip on Q4 s...
Source: Mass Device - March 13, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Senseonics Source Type: news

MRI Interventions posts revenue gain, lower loss in Q4
MRI Interventions reported an increase in total revenue in its fourth quarter,...Read more on AuntMinnie.comRelated Reading: Siemens and MRI Interventions sign MRI deal FDA clears therapy product from MRI Interventions MRI Interventions teams with Voyager Therapeutics MRI Interventions to raise $13M in private placement MRI Interventions partners with Mayo Clinic (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2019 Category: Radiology Source Type: news

Stratasys shares rise on Q4 earnings release
Shares in Stratasys (NSDQ:SSYS) rose today after the 3D-printing giant met expectations on Wall Street with its fourth quarter and full year 2018 earnings release. Minneapolis- and Rehovot, Israel-based Stratasys posted profits of $6.3 million, or 12¢ per share, on sales of $177.1 million for the three months ended December 31, seeing a swing from red ink in the bottom line while sales shrunk 1.2% compared with the same period during the previous year. Read the whole story on our sister site, Medical Design & Outsourcing The post Stratasys shares rise on Q4 earnings release appeared first on MassDevice. ...
Source: Mass Device - March 8, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat stratasys Source Type: news

T2 Biosystems shares tumble on 2018 earnings release
Shares in T2 Biosystems (NSDQ:TTOO) have fallen nearly 20% today after the diagnostics maker posted its full year 2018 earnings. For the full year, the Lexington, Mass.-based company posted losses of $51.2 million, or $1.26 per share, on sales of $10.5 million, seeing losses shrink 18.1% while sales grew 125% compared with the previous year. For its fourth quarter, T2 Biosystems reported total sales of $1.8 million, up 6% when compared to the same period during the previous year. “2018 was a year of major achievements for the company highlighted by the FDA clearance of the T2Bacteria panel, which has driven reco...
Source: Mass Device - March 8, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics MassDevice Earnings Roundup Wall Street Beat T2 Biosystems Inc. Source Type: news

Ocular Therapeutix posts mixed Q4 results
Shares in Ocular Therapeutix (NSDQ:OCUL) fell in premarket activity today after the company posted mixed fourth-quarter results. The Bedford, Mass.-based company posted a net loss of -$17.4 million, or -42¢ per share, on sales of $504,000 for the three months ended Dec. 31, for sales growth of 3.5% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Ocular Therapeutix posts mixed Q4 results appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 8, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations MassDevice Earnings Roundup Optical/Ophthalmic Pharmaceuticals Wall Street Beat oculartherapeutix Source Type: news

Avinger shares rise despite Q4 earnings miss
Shares in Avinger (NSDQ:AVGR) have risen today despite the medical device maker posting fourth quarter earnings that missed expectations on Wall Street. The Redwood City, Calif.-based company posted losses of $6.9 million, or 31¢ per share, on sales of $2 million for the three months ended December 31, seeing losses shrink 31.8% while sales grew 6% compared with the same period during the previous year. Losses per share were just behind the 29¢ consensus on Wall Street for the quarter. For the full year, Avinger posted losses of $35.7 million, or $3.34 per share, on sales of $7.9 million, seeing losses shrin...
Source: Mass Device - March 7, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Avinger Source Type: news

InfuSystem reports Q4, FY18 financial results
Shares in InfuSystem (NYSE:INFU) ticked up slightly today after the company reported its fourth-quarter and full-year financial results. The Michigan-based company posted a net loss of -$275k, or -1¢ per share, on sales of $17.6 million for the three months ended Dec. 31. Sales were down 7% compared to the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post InfuSystem reports Q4, FY18 financial results appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 7, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations MassDevice Earnings Roundup Oncology Pharmaceuticals Wall Street Beat InfuSystem Source Type: news

Axonics Modulation Technologies slides on misses Q4, 2018 earnings
Axonics Modulation Technologies (NSDQ:AXNX) took a hit after it posted fourth-quarter and 2018 losses that exceeded the consensus forecast on Wall Street. The company is developing a sacral nerve stimulation device to treat incontinence. Irvine, Calif.-based Axonics said yesterday that its losses grew 95.6% to -$9.6 million, or -50¢ per share, on sales of $494,000 for the three months ended Dec. 31, 2018, compared with the same period in 2017. Analysts on The Street were expecting losses of -32¢ on sales of $220,000. Full-year losses also grew, rising 86.0% to -$32.5 million, or -$4.64 per share, on sales growth ...
Source: Mass Device - March 6, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Neuromodulation/Neurostimulation Wall Street Beat Axonics Modulation Technologies Source Type: news

Cooper Cos. shares rise on FY2019 Q1 earnings beat
Shares in Cooper Cos. (NYSE:COO) have risen in after-hours trading today after the company reported first quarter fiscal year 2019 earnings that beat expectations on Wall Street. The Pleasanton, Calif.-based company reported profits of $103.2 million, or $2.07 per share, on sales of $628.1 million for the three months ended January 31, seeing a swing from red ink on the bottom line while sales grew 6.5% compared with the same period during the previous year. After adjusting to exclude one-time items, earnings per share were $2.88, well ahead of the $2.50 consensus on Wall Street where analysts expected too see sales of $61...
Source: Mass Device - March 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat CooperSurgical CooperVision The Cooper Cos. Source Type: news

Valeritas posts mixed Q4 results
Valeritas (NSDQ:VLRX) posted its fourth-quarter and full-year financial results today, missing earnings estimates but topping revenue expectations on Wall Street. The Bridgewater, N.J.-based company posted a net loss of -$11.9 million on sales of $6.89 million for the three months ended Dec. 31, for sales growth of 19% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas posts mixed Q4 results appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 5, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Featured MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Valeritas Source Type: news

Align Tech to close InvisAlign stores as result of arbitration with Smile Direct Club
Align Technology (NSDQ:ALGN) said today that it is closing its Invisalign stores due to the outcome of arbitration with SmileDirectClub. San Jose, Calif.-based Align Technology, known for its clear orthodontic alignment devices, said that it will close its Invisalign stores by April 3. The stores were first piloted in 2017 and have since expanded into 12 locations by last year, the company said. The arbitration between Smile Direct Club and Align Technology concluded on January 23, with the arbitrator releasing his decision on March 4. In his decision, the arbitrator held that Align breached a non-compete provision ap...
Source: Mass Device - March 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dental aligntechnology Source Type: news

ICU Medical posts Street-beating Q4
ICU Medical (NSDQ:ICUI) last week posted fourth quarter earnings that topped earnings-per-share expectations on Wall Street. The San Clemente, Calif.-based company posted losses of approximately $7.4 million, or 36¢ per share, on sales of approximately $340.4 million for the three months ended December 31, seeing a swing into red ink on the bottom line while sales shrunk 8% when compared to the same period during the previous year. After adjusting to exclude one-time items, earnings per share were $2.07, ahead of the $1.80 consensus on Wall Street. For the full year, ICU Medical posted profits of approximate...
Source: Mass Device - March 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat ICU Medical Inc. Source Type: news

Medical News Today: The key to weight loss: 'Log often, lose more'
Contrary to popular opinion, dietary self-monitoring, which is one of the most effective ways to lose weight, takes less than quarter of an hour each day. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 3, 2019 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

RTI Surgical ticks up on swing to Q4 black
Shares in RTI Surgical (NSDQ:RTIX) ticked up today on the the medical device company’s report yesterday of a swing to black ink for the fourth quarter. Alachua, Fla.-based RTI posted profits of $2.1 million, or 3¢ per share, on sales of $71.2 million for the three months ended Dec. 31, 2018, compared with losses of -$8.6 million during the same period in 2017 year and amounting to sales growth of 0.6%. Analysts on Wall Street were looking for earnings per share of 1¢. Full-year losses were -$3.4 million, or -5¢ per share, on sales of $280.9 million, marking a swing to red from profits of $2.5 million f...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat RTI Surgical Source Type: news

SeaSpine posts Q4 EPS miss
Shares in SeaSpine Holdings (NSDQ:SPNE) are down slightly today after the medical device maker posted fourth quarter earnings there missed earnings-per-share expectations on Wall Street. The Carlsbad, Calif.-based company posted losses of $9.5 million, or 53¢ per share, on sales of $38 million for the three months ended December 31, seeing losses grow 26.9% while sales grew 11.9% compared with the same period during the previous year. Losses per share were behind the 42¢ loss-per-share consensus on Wall Street. For the full year, SeaSpine reported losses of $33.5 million, or $2.18 per share, on sales of $143...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat SeaSpine Source Type: news

Cantel Medical slumps on fiscal Q2 misses
Cantel Medical (NYSE:CMD) shares took a hit this week when the medical device company missed the consensus forecast with its fiscal second-quarter results. Little Falls, N.J.-based Cantel posted a -42.1% profit slide to $18.8 million, or 45¢ per share, on sales of $224.5 million for the three months ended Jan. 31, for top-line growth of 5.4% compared with fiscal Q2 2018. Adjusted to exclude one-time items, earnings per share were 57¢, a nickel below the consensus on Wall Street, where analysts were looking for revenues of $226.9 million. “We are pleased to see continued strong double-digit sales growth...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat Cantel Medical Corp. Source Type: news

AtriCure shares dip despite Q4 earnings beat
Shares in AtriCure (NSDQ:ATRC) have fallen slightly today despite the medical device maker posting fourth quarter earnings that topped expectations on Wall Street. The Mason, Ohio-based company posted losses of $3.4 million, or 9¢ per share, on sales of $52.9 million for the three months ended December 31, seeing losses grow 32.9% while sales grew 14.8% compared with the same period during the previous year. Losses per share were ahead of the 17¢ loss-per-share consensus on Wall Street. For the full year, AtriCure posted losses of $21.1 million, or 62¢ per share, on sales of $201.6 million, seeing losse...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat AtriCure Inc. Source Type: news

Novocure shares dip on Q4, 2018 earnings miss
Shares in Novocure (NSDQ:NVCR) fell slightly today after the medical device maker missed expectations on Wall Street with its fourth quarter and full year 2018 earnings release. The St. Helier, Jersey-based company posted losses of $15.6 million, or 17¢ per share, on sales of $69.7 million for the three months ended December 31, seeing losses grow 42.8% while sales grew 29.8% compared with the same period during the previous year. Read the whole story on our sister site, Drug Delivery Business News The post Novocure shares dip on Q4, 2018 earnings miss appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 28, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat NovoCure Source Type: news

Glaukos rises on Street-beating Q4, 2018 earnings
Shares in Glaukos (NYSE:GKOS) are rising today after the ophthalmological-focused medical device maker posted fourth quarter and full year 2018 earnings that topped expectations on Wall Street. The San Clemente, Calif.-based company posted profits of approximately $1.8 million, or 4¢ per share, on sales of approximately $54.1 million for the three months ended December 31, for bottom-line growth of 76.8% while sales grew 29.8% compared with the same period during the previous year. Read the whole story on our sister site, Drug Delivery Business News The post Glaukos rises on Street-beating Q4, 2018 earnings appea...
Source: Mass Device - February 28, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Optical/Ophthalmic Wall Street Beat Glaukos Source Type: news

Boca Raton Regional Hospital takes quarterly loss from stock market slump
The hospital is set for a merger with Baptist Health South Florida. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 27, 2019 Category: Biotechnology Authors: Brian Bandell Source Type: news

Penumbra revenue up but earnings down in Q4
Penumbra (NYSE:PEN) saw its revenue jump more than 25% year-over-year in the fourth quarter, but earnings were down for the Alameda, Calif.–based maker of devices to treat neuro and peripheral vascular conditions. Alameda, Calif.-based Penumbra’s stock is down about $15.57 per share, or 10.6%, to $131.25 as of midday trading. The company reported yesterday evening that it earned $6.7 million, or 18 cents per share, for the quarter ended Dec. 31, down from $9.1 million, or 25 cents per share, for the same quarter a year before. Revenue was $120.8 million, up 25.8% year-over-year. Analysts polled by Yahoo! F...
Source: Mass Device - February 27, 2019 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Cardiovascular Neurological News Well Wall Street Beat Penumbra Inc. Source Type: news

Endologix misses the mark with Q4, 2018 numbers
The objectives we accomplished during the second half of 2018 align with those we laid out during our second-quarter earnings call as part of our strategic reset. As we enter 2019, our single biggest lever will be a consistent and unwavering application of individual and company-wide accountability. We will lean heavily on this lever throughout the year as the critical enabler of consistent delivery on our commitments to patients, customers, investors and other stakeholders. We are determined to sustain the momentum generated over the last two quarters as we continue to take steps to improve the company’s operational...
Source: Mass Device - February 27, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Stent Grafts Wall Street Beat Endologix Source Type: news

LivaNova shares dip despite Q4, 2018 earnings beat
Shares in LivaNova (NSDQ:LIVN) fell today despite the medical device maker posting fourth quarter and full year 2018 earnings that topped expectations on Wall Street. The London-based company posted losses of $210.6 million, or $4.34 per share, on sales of $297 million for the three months ended December 31, seeing losses grow 88.5% while sales grew 6.7% compared with the same period during the previous year. Adjusted to exclude one-time items, earnings per share were $1.12, just ahead of the $1.10 consensus on Wall Street where analysts expected to see sales of $295 million, which the company topped. For the full yea...
Source: Mass Device - February 27, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat LivaNova Source Type: news

Mylan shares down on mixed Q4 results
Shares in Mylan (NSDQ:MYL) fell yesterday after the company missed earnings expectations but beat sales estimates on Wall Street with its fourth-quarter financial results. The Pittsburgh, PA-based company posted profits of $51.2 million, or 10¢ per share, on sales of $3.04 billion for the three months ended Dec. 31, for bottom-line loss of -79% on sales loss of -5% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Mylan shares down on mixed Q4 results appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 27, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Mylan Source Type: news

Merit Medical ’ s Q4, 2018 top The Street
Merit Medical (NSDQ:MMSI) yesterday posted fourth-quarter and full-year sales and earnings that beat the consensus forecast on Wall Street. The South Jordan, Utah-based medical device company reported profits of $9.2 million, or 16¢ per share, on sales of $233.2 million for the three months ended Dec. 31, 2018, representing bottom-line growth of 35.0% on sales growth of 22.2% compared with Q4 2017. Adjusted to exclude one-time items, earnings per share were 48¢, three pennies ahead of The Street, where analysts were looking for sales of $230.4 million. Full-year profits grew 52.7% to $42.0 million, or 78&cen...
Source: Mass Device - February 27, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat Merit Medical Systems Source Type: news

Wright Medical posts street-beating Q4, 2018 earnings
Wright Medical (NSDQ:WMGI) today posted fourth quarter and full year 2018 earnings that beat expectations on Wall Street. The Amsterdam-based company posted losses of approximately $33.8 million, or 27¢ per share, on sales of $238.1 million for the three months ended December 31, seeing a swing into red ink while sales grew 9.4% compared with the same period during the previous year. After adjusting to exclude one-time items, earnings per share were 11¢, ahead of the 5¢ consensus on Wall Street, where analysts expected to see sales of approximately $237 million, which the company topped. For the fu...
Source: Mass Device - February 26, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat wrightmedical Source Type: news

Orthofix slumps on top-line misses, CEO Mason to retire
Orthofix (NSDQ:OFIX) missed the consensus for its fourth-quarter and 2018 sales, sending its share price down by double digits today in mid-afternoon trading despite a huge bottom-line gain. Lewisville, Texas-based Orthofix reported profits were up 465.8% to $8.9 million, or 46¢ per share, on sales growth of 3.6% to $121.1 million compared with Q4 2017. Adjusted to exclude one-time items, earnings per share were 55¢, 7¢ ahead of the consensus on Wall Street; however, analysts there were looking for sales of $121.5 million. “With the recent FDA approval of the M6-C artificial cervical disc, the pri...
Source: Mass Device - February 26, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Orthopedics Wall Street Beat Orthofix Personnel Moves Source Type: news

Intersect ENT shares dip despite street-beating Q4, 2018 earnings
Shares in Intersect ENT (NSDQ:XENT) have fallen slightly today despite the medical device maker released fourth quarter and full year 2018 earnings that met consensus expectations from analysts on Wall Street. The Menlo Park, Calif.-based company posted losses of $5 million, or 16¢ per share, on sales of approximately $32.8 million for the three months ended December 31, seeing losses grow 59.6% while sales grew 11% compared with the same period during the previous year. Read the whole story on our sister site Drug Delivery Business News The post Intersect ENT shares dip despite street-beating Q4, 2018 earnings a...
Source: Mass Device - February 26, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat intersectent Source Type: news

Transenterix shares down on mixed-bag Q4 earnings release
Shares in TransEnterix (NYSE:TRXC) fell today after the medical device maker posted fourth quarter earnings that fell short on loss-per-share expectations but topped sales consensus on Wall Street. The Research Triangle Park, N.C.-based company posted losses of $6.4 million, or 3¢ per share, on sales of $7.5 million for the three months ended December 31, seeing losses shrink 91.5% while sales grew 121.4% compared with the same period during the previous year. After adjusting to exclude one-time items, losses per share were 7¢, just behind the 6¢ loss-per-share expectation on Wall Street, where analysts...
Source: Mass Device - February 26, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat TransEnterix Source Type: news

Insulet tops estimates with Q4 results
Insulet (NSDQ:PODD) posted its fourth-quarter and full-year financial results yesterday after the markets closed, beating estimates on Wall Street. The Acton, Mass.-based company posted profits of $9.9 million, or 17¢ per share, on sales of $164.9 million for the three months ended Dec. 31. It was the first time in the company’s history that it recorded a quarterly profit rather than a net loss. Q4 sales were up 26% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Insulet tops estimates with Q4 results appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 26, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Diabetes Drug-Device Combinations Featured MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Insulet Source Type: news

Nevro shares down on Q4, 2018 miss
Shares in Nevro (NYSE:NVRO) fell today after the medical device maker released fourth quarter and full year 2018 earnings that missed loss-per-share expectations on Wall street. The Redwood City, Calif.-based company posted losses of $9.7 million, or 32¢ per share, on sales of $107.9 million for the three months ended December 31, seeing losses grow 97.1% while sales grew 10.2% compared with the same period during the previous year. Losses per share for the quarter were just behind the 21¢ consensus on Wall Street, where analysts expected to see sales of $107.1 million, which the company topped. For the full...
Source: Mass Device - February 22, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Nevro Corp. Source Type: news

Dexcom beats The Street with Q4, FY18 results
Dexcom (NSDQ:DXCM) topped expectations on Wall Street this week with its fourth quarter and full-year financial results. The San Diego, Calif.-based company posted a net loss of -$179.7 million, or -$2.03 per share, on sales of $338 million for the 3 months ended Dec. 31, for sales growth of 52.9% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Dexcom beats The Street with Q4, FY18 results appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 22, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Featured MassDevice Earnings Roundup Wall Street Beat Dexcom Source Type: news

Teleflex shares dip on Q4, 2018 earnings release, restructuring announcement
Shares in Teleflex (NYSE:TFX) have fallen today after the medical device maker released fourth quarter and full year 2018 earnings mostly in line with analysts expectations, as well as a 3-year, $56 million restructuring plan. The Wayne, Penn.-based company posted profits of approximately $90.6 million, or $1.93 per share, on sales of $641.6 million for the three months ended December 31, seeing a swing from red ink on the bottom line while sales grew 7.8% compared with the same period during the previous year. Adjusted to exclude one-time items, earnings per share were $2.77, just ahead of the $2.76 consensus on Wall...
Source: Mass Device - February 21, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat Teleflex Source Type: news

NuVasive shares rise on Q4, 2018 EPS beat
Shares in NuVasive Inc. (NSDQ:NUVA) have risen slightly today after the medical device maker beat earnings per share expectations on Wall Street with its fourth quarter and full year 2018 earnings report. The San Diego-based company posted profits of approximately $12.2 million, or 23¢ per share, on sales of $288.3 million for the three months ended December 31, seeing profits shrink 48.2% while sales grew 6.3% compared with the same period during the previous year. After adjusting to exclude one-time items, earnings per share were 69¢, just ahead of the 63¢ consensus on Wall Street where analysts expec...
Source: Mass Device - February 21, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat Nuvasive Source Type: news

CVS drops $7B in market cap as it predicts rough year ahead
Coming off a $69 billion merger with national insurer Aetna, CVS is predicting a difficult year ahead, and investors aren ’t happy. The stock lost nearly 8 percent on Wednesday — representing a loss of more than $7 billion in market capitalization — after the Rhode Island-based company (NYSE: CVS) reported fourth quarter earnings. The stock drop to $64.22 a share at the close of markets was the worst day for the company's shares since November 2016, according to CNBC. The loss came after the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 20, 2019 Category: American Health Authors: Jessica Bartlett Source Type: news

Owens & Minor dips on Q4, 2018 EPS miss
Shares in Owens & Minor (NYSE:OMI) fell today after the medical device maker missed earnings per share expectations on Wall Street with its fourth quarter and full year 2018 earnings results. The Richmond, Va.-based company posted losses of approximately $261.8 million, or $4.37 per share, on sales of approximately $2.54 billion for the three months ended December 31, seeing a massive swing into the red on the bottom line while sales grew 6.4% compared with the same period during the previous year. After adjusting to exclude one-time items, earnings per share were 9¢, behind the 14¢ consensus on Wall Str...
Source: Mass Device - February 20, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat owensminor Source Type: news

Henry Schein shares drop on mixed bag Q4 earnings
Shares in Henry Schein (NSDQ:HSIC) fell today after the medical device maker posted fourth quarter and full year 2018 earnings that beat earnings per share expectations but missed on revenue consensus. The Melville, N.Y.-based company posted profits of approximately $133 million, or 87¢ per share, on sales of approximately $3.38 billion for the three months ended December 29, seeing a swing from red ink on the bottom line while sales grew 1.7% compared with the same period during the previous year. After adjusting to exclude one-time items, earnings per share were $1.12, just ahead of the $1.11 consensus on Wall ...
Source: Mass Device - February 20, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Henry Schein Inc. Source Type: news

NuVasive wins FDA, CE Mark for Precice internal bone transport system
NuVasive Inc. (NSDQ:NUVA) said today that it won FDA 510(k) clearance and CE Mark clearance in the European Union for its Precice bone transport system. The San Diego, Calif.-based company touted the system as the only all-internal system indicated for use in segmental bone loss treatment in the tibia and femur resulting from trauma or infection. The Precice bone transport system includes an implantable magnetic intramedullary nail with a dual slot intended to support the transport of an intercalary bone segment to allow for health regeneration, NuVasive said. Following implantation, an external remote control is used...
Source: Mass Device - February 19, 2019 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Featured Food & Drug Administration (FDA) Orthopedics Regulatory/Compliance Nuvasive Source Type: news

Medtronic shares rise on FY2019 Q3 earnings beat
Shares in Medtronic (NYSE:MDT) are up today after the medical device giant posted third quarter fiscal year 2019 earnings that beat expectations on Wall Street. The Fridley, Minn.-based company posted profits of approximately $1.27 billion, or 94¢ per share, on sales of approximately $7.55 billion for the three months ended January 25, seeing a swing from red ink on the bottom line while sales grew 2.4% compared with the same period during the previous fiscal year. After adjusting to exclude one-time items, earnings per share were $1.27, just ahead of the $1.24 consensus on Wall Street where analysts expected to ...
Source: Mass Device - February 19, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat Medtronic Source Type: news

Medtronic beats estimates on Q3 and hikes earnings outlook
Medtronic posted better-than-expected sales and profits for the med-tech giant's fiscal third quarter. MarketWatch has an early report on the numbers from Medtronic, which is legally headquartered in Dublin but has its management base in Fridley. For the quarter ended Jan. 25, Medtronic (NYSE: MDT) posted earnings of $1.27 billion, or 94 cents a share, down from $1.59 billion, or $1.17 per share in the same period a year ago. Excluding one-time effects, adjusted earnings came to $1.29 per share,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 19, 2019 Category: Biotechnology Authors: Mark Reilly Source Type: news

Medtronic beats estimates on Q3 and hikes earnings outlook
Medtronic posted better-than-expected sales and profits for the med-tech giant's fiscal third quarter. MarketWatch has an early report on the numbers from Medtronic, which is legally headquartered in Dublin but has its management base in Fridley. For the quarter ended Jan. 25, Medtronic (NYSE: MDT) posted earnings of $1.27 billion, or 94 cents a share, down from $1.59 billion, or $1.17 per share in the same period a year ago. Excluding one-time effects, adjusted earnings came to $1.29 per share,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 19, 2019 Category: American Health Authors: Mark Reilly Source Type: news

Baptist Health battered by stock market in quarterly loss
The hospital recently opened a hotel near its main campus. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 15, 2019 Category: American Health Authors: Brian Bandell Source Type: news

Baptist Health battered by stock market in quarterly loss
The hospital recently opened a hotel near its main campus. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2019 Category: Biotechnology Authors: Brian Bandell Source Type: news

Titan Medical hopeful for Q4 FDA IDE trial launch for Sport robotic platform
Robotic surgical platform developer Titan Medical (NSDQ:TMDI) said late yesterday that it is hoping to launch an FDA investigational device exemption trial of its Sport robotic surgery platform by the fourth quarter of this year. The news came as part of the Toronto-based company’s 2018 earnings report, with the robotic surgical company saying that it is hopeful it will finish verification and validation testing followed by design freeze and animal and cadaver studies to support regulatory clearance filings during the first half of 2019. Following that testing, Titan Medical said it hopes to submit an IDE s...
Source: Mass Device - February 14, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Clinical Trials Featured Robotics Surgical Titan Medical Inc. Source Type: news

ReWalk Robotics touts first U.S. insurer reimbursement win for exoskeleton devices
ReWalk Robotics (NSDQ:RWLK) said today that health insurer Cigna will now review submissions for the use of exoskeleton devices for individuals with spinal cord injuries after a change to its coverage policies. The Yokneam, Israel-based company touted the shift as the first of its kind by a major private insurer in the U.S. The policy change has already taken effect, with a formal policy change slated to be performed by Cigna “in or around Q3 2019,” ReWalk said. “This is a major milestone for healthcare beneficiaries in the United States. Cigna is leading by example with its understanding of eme...
Source: Mass Device - February 13, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Robotics ReWalk Robotics Source Type: news

Fonar posts mixed results in Q2
MRI vendor Fonar posted a gain in net total revenue but took a hit in net income...Read more on AuntMinnie.comRelated Reading: Fonar's revenue, income rise in 2nd quarter Fonar posts revenue increase in Q1 Fonar posts year-end revenue increases Fonar posts mixed Q2 results Fonar boosts revenues, profits in Q1 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 11, 2019 Category: Radiology Source Type: news